Impact on outcome and healthcare costs from hemodynamic optimization in patients undergoing pancreatic surgery: A preliminary report

Perilli, Valter; Aceto, Paola; Russo, A.; Romano, B.; Quero, Giuseppe; Di Miceli, Dario; Alfieri, Sergio; Berrito, A. M.; Cicchetti, Americo; Sollazzi, Liliana

doi:10.1109/MeMeA.2018.8438724

Aim of this study was to evaluate if the use of a fluid-therapy protocol performed by a minimally-invasive hemodynamic device could improve outcome and reduce healthcare costs in patients undergoing pancreatic surgery.One-hundred-seventy-three patients undergoing pancreatic surgery were included in this before-and-after study. Patients underwent a goal-directed fluid-therapy (GDFT group) regimen by the Vigileo/FloTrac system following NICE (National Institute for Health and Care Excellence) protocol (GDFT, n=69 pts). The control group (CON group) consisted of 104 patients who underwent the same type of surgery in the previous 2 years. In CON group patients fluid-therapy was managed on the basis of conventional hemodynamic parameters. Exclusion criteria were age [removed]

Perilli, V., Aceto, P., Russo, A., Romano, B., Quero, G., Di Miceli, D., Alfieri, S., Berrito, A. M., Cicchetti, A., Sollazzi, L., Impact on outcome and healthcare costs from hemodynamic optimization in patients undergoing pancreatic surgery: A preliminary report, <<MeMeA 2018 - 2018 IEEE International Symposium on Medical Measurements and Applications, Proceedings>>, 2018; (N/A): 1-6. [doi:10.1109/MeMeA.2018.8438724] [https://hdl.handle.net/10807/248797]